tiprankstipranks
pc:ambro

Ambros Therapeutics

18575 Jamboree Road Suite 275-S Irvine, CA 92612, US
https://ambrostherapeutics.com/
Ambros Therapeutics is a clinical-stage biotechnology company focused on the development of innovative and transformative medicines for diseases with high unmet medical need. The company's lead investigational program targets Complex Regional Pain Syndrome Type 1 (CRPS-1).

Leadership & Board

Current Number of Employees28
Current LinkedIn Followers1,061

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$125M
Total Amount Raised$125M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$125M
Latest Funding Amount$125M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Company Momentum Positive

Articles Published on TipRanks2
Articles Published on TipRanks
2
LinkedIn Trend+1.73% followers
LinkedIn Trend
+1.73% followers
Workforce Trend+3.7% employees
Workforce Trend
+3.7% employees
Ambros Therapeutics LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.

Employee Trend

Ambros Therapeutics had 28 employees as of April 6, 2026. The number of employees increased by 1 (3.70%) week-over-week.
28Latest Employee Count
1(3.70%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Ambros Therapeutics had 1,061 followers as of April 6, 2026. The number of followers increased by 18 (1.73%) week-over-week.
1,061Latest Followers Count
18(1.73%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Dec 16, 2025
Series A
$125.00M

Related News and Analysis